Device Trial Radar · NCT01197547
Registry Study of Genesys HTA for Treatment of Menorrhagia
Last checked: Nov 19, 2026Latest source record: Mar 26, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,014
Actual
Start
Nov 2010
Primary completion
Feb 2012
Study completion Aug 2012
Sponsor
- Lead sponsor
- Minerva Surgical, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Sep 9, 2010
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a clinical registry of an FDA approved device system called the Genesys Hydro ThermAblatorTM (HTA) system (Boston Scientific). The HTA system's intended use is to be inserted, by a trained physician, into the uterus, where it will fill and circulate fluid that is warm enough to change the characteristics of the uterine lining. This is done with the anticipated result of improving menstrual bleeding symptoms. The purpose of this FDA-mandated registry is to obtain clinical experience on the use the Genesys HTA™ system, under normal clinical conditions, and document its safety and technical reliability.
Conditions
- Menorrhagia
Interventions
Genesys HTADevice
Genesys HTA Endometrial Ablation
Primary outcomes
What the sponsor says the trial is designed to measure.
- Burn RateTime frame: Day 1
Locations
19 sites in 1 country. Site status is shown where the registry gives one.
Sharp Mary Birch
San Diego, California
Christiana Hospital
Newark, Delaware
Shelnutt Obstetrics and Gynecology
Athens, Georgia
16 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.